{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:21:50Z","timestamp":1786119710707,"version":"build-2736575974"},"reference-count":62,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1097\/crd.0b013e318214022b","type":"journal-article","created":{"date-parts":[[2011,4,2]],"date-time":"2011-04-02T00:00:42Z","timestamp":1301702442000},"page":"122-129","source":"Crossref","is-referenced-by-count":4,"title":["Contemporary In-Hospital Management Strategies for Acute Decompensated Heart Failure"],"prefix":"10.1097","volume":"19","author":[{"given":"Carlos E.","family":"Sanchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210203","article-title":"Heart disease and stroke statistics\u20142006 Update.","year":"2006"},{"issue":"suppl 7","key":"R2-4-20210203","first-page":"S21","article-title":"The Acute Decompensated Heart Failure National Registry (ADHERE): opportunities to improve care of patients hospitalized with acute decompensated heart failure.","volume":"4","author":"Fonarow","year":"2003","journal-title":"Rev Cardiovasc Med"},{"key":"R3-4-20210203","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0002-9149(01)01554-5","article-title":"Socioeconomic status as an independent risk factor for hospital readmission for heart failure.","volume":"87","author":"Philbin","year":"2001","journal-title":"Am J Cardiol"},{"key":"R4-4-20210203","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2008.11.013","article-title":"2009 focused update incorporated into the ACC\/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines developed in collaboration with the International Society for Heart and Lung Transplantation.","volume":"53","author":"Hunt","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R5-4-20210203","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/S0735-1097(03)00309-7","article-title":"Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure.","volume":"41","author":"Nohria","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R6-4-20210203","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1093\/eurheartj\/ehn309","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology.","volume":"29","author":"Dickstein","year":"2008","journal-title":"Eur Heart J"},{"key":"R7-4-20210203","doi-asserted-by":"crossref","first-page":"e475","DOI":"10.1016\/j.cardfail.2010.04.005","article-title":"Executive summary: HFSA 2010 comprehensive heart failure practice guideline.","volume":"16","author":"Lindenfeld","year":"2010","journal-title":"J Card Fail"},{"key":"R8-4-20210203","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJMoa020233","article-title":"Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.","volume":"347","author":"Maisel","year":"2002","journal-title":"N Engl J Med"},{"key":"R9-4-20210203","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/j.jacc.2007.02.037","article-title":"Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure.","volume":"49","author":"Fonarow","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R10-4-20210203","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jacc.2003.09.044","article-title":"Pre-discharge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure.","volume":"43","author":"Logeart","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R11-4-20210203","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1161\/01.CIR.0000165065.82609.3D","article-title":"Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure.","volume":"111","author":"Klein","year":"2005","journal-title":"Circulation"},{"key":"R12-4-20210203","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1001\/jama.293.5.572","article-title":"Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis.","volume":"293","author":"Fonarow","year":"2005","journal-title":"JAMA"},{"key":"R13-4-20210203","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2008.07.051","article-title":"Cardiorenal syndrome.","volume":"52","author":"Ronco","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R14-4-20210203","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/eurheartj\/ehp507","article-title":"Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative.","volume":"31","author":"Ronco","year":"2010","journal-title":"Eur Heart J"},{"key":"R15-4-20210203","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jacc.2008.05.068","article-title":"Importance of venous congestion for worsening of renal function in advanced decompensated heart failure.","volume":"53","author":"Mullens","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R16-4-20210203","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jacc.2007.09.043","article-title":"Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function?","volume":"51","author":"Mullens","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R17-4-20210203","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.cardfail.2004.02.011","article-title":"Risk stratification after hospitalization for decompensated heart failure.","volume":"10","author":"Felker","year":"2004","journal-title":"J Card Fail"},{"key":"R18-4-20210203","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1001\/jama.290.19.2581","article-title":"Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model.","volume":"290","author":"Lee","year":"2003","journal-title":"JAMA"},{"key":"R19-4-20210203","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jacc.2008.04.028","article-title":"Predictors of in-hospital mortality in patients hospitalized for heart failure.","volume":"52","author":"Abraham","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R20-4-20210203","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1751-7133.2009.00112.x","article-title":"Early vasoactive drugs improve heart failure outcomes.","volume":"15","author":"Peacock","year":"2009","journal-title":"Congest Heart Fail"},{"key":"R21-4-20210203","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jacc.2008.05.010","article-title":"Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE analysis.","volume":"52","author":"Maisel","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R22-4-20210203","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1161\/CIR.0b013e3181f9a223","article-title":"the American Heart Association Council on Clinical Cardiology and Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation. Acute heart failure syndromes: emergency department presentation, treatment, and disposition: current approaches and future aims: a scientific statement from the American Heart Association.","volume":"122","author":"Weintraub","year":"2010","journal-title":"Circulation"},{"issue":"suppl l","key":"R23-4-20210203","first-page":"S12","article-title":"Congestion is an important diagnostic and therapeutic target in heart failure.","volume":"7","author":"Gheorghiade","year":"2006","journal-title":"Rev Cardiovasc Med"},{"key":"R24-4-20210203","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0140-6736(97)08417-1","article-title":"Randomized trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary edema.","volume":"351","author":"Cotter","year":"1998","journal-title":"Lancet"},{"key":"R25-4-20210203","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ahj.2003.08.012","article-title":"Relationship between heart failure treatment and development of worsening renal function among hospitalized patients.","volume":"147","author":"Butler","year":"2004","journal-title":"Am Heart J"},{"key":"R26-4-20210203","first-page":"CD003178","article-title":"Continuous infusion versus bolus injection of loop diuretics in congestive heart failure.","author":"Salvador","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"R28-4-20210203","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.jacc.2005.05.099","article-title":"Early ultrafiltration in patients with decompensated heart failure and diuretic resistance.","volume":"46","author":"Costanzo","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R29-4-20210203","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jacc.2006.07.073","article-title":"Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure.","volume":"49","author":"Costanzo","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R30-4-20210203","doi-asserted-by":"crossref","first-page":"4A","DOI":"10.1016\/j.amjcard.2006.11.025","article-title":"Review of current and investigational pharmacologic agents for acute heart failure syndromes.","volume":"99","author":"Shin","year":"2007","journal-title":"Am J Cardiol"},{"key":"R31-4-20210203","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.emc.2005.07.005","article-title":"Modern management of cardiogenic pulmonary edema.","volume":"23","author":"Mattu","year":"2005","journal-title":"Emerg Med Clin North Am"},{"key":"R32-4-20210203","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jacc.2005.03.051","article-title":"In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the acute decompensated heart failure national registry (ADHERE).","volume":"46","author":"Abraham","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R33-4-20210203","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jacc.2008.02.083","article-title":"Sodium nitroprusside for advanced low-output heart failure.","volume":"52","author":"Mullens","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"1 suppl 1","key":"R34-4-20210203","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1527-5299.2004.03310.x","article-title":"B-type natriuretic peptide: the level and the drug-partners in the diagnosis and management of congestive heart failure.","volume":"10","author":"Bhalla","year":"2004","journal-title":"Congest Heart Fail"},{"key":"R35-4-20210203","first-page":"1531","article-title":"Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.","volume":"287","year":"2002","journal-title":"JAMA"},{"key":"R36-4-20210203","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/01.CIR.0000159340.93220.E4","article-title":"Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure.","volume":"111","author":"Sackner-Bernstein","year":"2005","journal-title":"Circulation"},{"key":"R37-4-20210203","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1001\/jama.293.15.1900","article-title":"Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials.","volume":"293","author":"Sackner-Bernstein","year":"2005","journal-title":"JAMA"},{"key":"R38-4-20210203","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.ahj.2006.07.002","article-title":"Short and long term mortality with nesiritide.","volume":"152","author":"Arora","year":"2006","journal-title":"Am Heart J"},{"key":"R39-4-20210203","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/CIRCHEARTFAILURE.108.767483","article-title":"Safety and efficacy of outpatient nesiritide in patients with advanced heart failure. Results of the second follow-up serial infusions of nesiritide (FUSION II) trial.","volume":"1","author":"Yancy","year":"2008","journal-title":"Circ Heart Fail"},{"key":"R40-4-20210203","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.jacc.2007.03.071","article-title":"Impact of nesiritide on renal function in patients with acute decompensated heart failure and pre-existing renal dysfunction: a randomized, double-blind, placebo-controlled clinical trial.","volume":"50","author":"Witteles","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R42-4-20210203","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/emj.2007.050419","article-title":"Morphine and outcomes in acute decompensated heart failure: an ADHERE analysis.","volume":"25","author":"Peacock","year":"2008","journal-title":"Emerg Med J"},{"key":"R43-4-20210203","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ahj.2006.09.005","article-title":"Use and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failure.","volume":"153","author":"Elkayam","year":"2007","journal-title":"Am Heart J"},{"key":"R44-4-20210203","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/jama.287.12.1541","article-title":"Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Investigators. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized control trial.","volume":"287","author":"Cuffe","year":"2002","journal-title":"JAMA"},{"key":"R45-4-20210203","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10741-008-9128-4","article-title":"Levosimendan: from basic science to clinical practice.","volume":"14","author":"Parissis","year":"2009","journal-title":"Heart Fail Rev"},{"key":"R46-4-20210203","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0140-6736(02)09455-2","article-title":"Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.","volume":"360","author":"Follath","year":"2002","journal-title":"Lancet"},{"key":"R47-4-20210203","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1053\/euhj.2001.3158","article-title":"Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN).","volume":"23","author":"Moiseyev","year":"2002","journal-title":"Eur Heart J"},{"key":"R48-4-20210203","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejheart.2005.12.003","article-title":"Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA,REVIVE-II, SURVIVE, and PROACTIVE.","volume":"8","author":"Cleland","year":"2006","journal-title":"Eur J Heart Fail"},{"key":"R49-4-20210203","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1001\/jama.297.17.1883","article-title":"Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE randomized trial.","volume":"297","author":"Mebazaa","year":"2007","journal-title":"JAMA"},{"key":"R51-4-20210203","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1016\/j.jacc.2008.03.015","article-title":"Hemodynamic, echocardiographic, and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure.","volume":"51","author":"Gheorghiade","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R52-4-20210203","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.ahj.2009.03.007","article-title":"Effects of istaroxime on diastolic stiffness in acute heart failure syndromes: results from the hemodynamic, echocardiographic, and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure (HORIZON-HF) trial.","volume":"157","author":"Shah","year":"2009","journal-title":"Am Heart J"},{"key":"R53-4-20210203","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1054\/jcaf.2003.24","article-title":"Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory endstage heart failure.","volume":"9","author":"Hershberger","year":"2003","journal-title":"J Card Fail"},{"key":"R54-4-20210203","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1161\/CIRCULATIONAHA.105.560110","article-title":"Contemporary use of digoxin in the management of cardiovascular disorders.","volume":"113","author":"Gheorghiade","year":"2006","journal-title":"Circulation"},{"key":"R55-4-20210203","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM199702203360801","article-title":"The effect of digoxin on mortality and morbidity in patients with heart failure.","volume":"336","year":"1997","journal-title":"N Eng J Med"},{"key":"R56-4-20210203","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1540-8191.2010.01018.x","article-title":"Mechanical circulatory support for AMI and cardiogenic shock.","volume":"25","author":"Abu-Omar","year":"2010","journal-title":"J Card Surg"},{"key":"R57-4-20210203","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1540-8191.2010.01038.x","article-title":"Mechanical circulatory support for bridge to decision: which device and when to decide.","volume":"25","author":"Ziemba","year":"2010","journal-title":"J Card Surg"},{"key":"R58-4-20210203","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1056\/NEJM199908193410806","article-title":"Hormones and hemodynamics in heart failure.","volume":"341","author":"Shrier","year":"1999","journal-title":"N Engl J Med"},{"key":"R59-4-20210203","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/CRD.0b013e3181f5b3b7","article-title":"Novel agents for the treatment of hyponatremia. A review of conivaptan and tolvaptan.","volume":"18","author":"Ferguson-Myrthil","year":"2010","journal-title":"Cardiol Rev"},{"key":"R60-4-20210203","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome trial.","volume":"297","author":"Konstam","year":"2007","journal-title":"JAMA"},{"key":"R61-4-20210203","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/jama.297.12.1332","article-title":"Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators. Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST clinical status trials.","volume":"297","author":"Gheorghiade","year":"2007","journal-title":"JAMA"},{"key":"R62-4-20210203","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.cardfail.2008.06.003","article-title":"Efficacy and safety of the vasopressin V1A\/V2-receptor antagonist conivaptan in acute decompensated heart failure: a dose-ranging pilot study.","volume":"14","author":"Goldsmith","year":"2008","journal-title":"J Card Fail"},{"key":"R63-4-20210203","doi-asserted-by":"crossref","first-page":"R250","DOI":"10.1152\/ajpregu.00672.2003","article-title":"Emerging role of relaxin in renal and cardiovascular function.","volume":"287","author":"Conrad","year":"2004","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"R64-4-20210203","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/CRD.0b013e3181f493e3","article-title":"Relaxin: a new approach for the treatment of acute congestive heart failure.","volume":"18","author":"Grossman","year":"2010","journal-title":"Cardiol Rev"},{"key":"R65-4-20210203","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(09)60622-X","article-title":"Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study.","volume":"373","author":"Teerlink","year":"2009","journal-title":"Lancet"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00045415-201105000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:59:40Z","timestamp":1786042780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00045415-201105000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/crd.0b013e318214022b","relation":{},"ISSN":["1061-5377"],"issn-type":[{"value":"1061-5377","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}